Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Rizon Dayang Pharmaceutical is a pharmaceutical manufacturing enterprise based in the Haikou National High-tech Industrial Development Zone in Hainan, China. The company specializes in the research, development, and large-scale production of generic drugs, with a primary focus on cardiovascular, anti-infective, and gastrointestinal therapeutic areas. Its manufacturing facilities are GMP-certified and capable of producing various dosage forms, including tablets, capsules, and granules. As a subsidiary of the Rizon Group, the company plays a significant role in the regional pharmaceutical supply chain, providing essential medications such as Amlodipine and Cefaclor to the Chinese market. The firm integrates modern production technology with rigorous quality control to maintain its competitive position in the domestic healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Rizon Dayang Pharmaceutical.